MedTrace Logo

Ultrasound-guided Thoracic Mid-Point Transverse Process to Pleural Block Versus Thoracic Paravertebral Block for Post Thoracotomy Analgesia

NCT07799844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-09-02

No results posted yet for this study

Summary

The aim of the study is to compare the analgesic efficacy and safety of midpoint transverse process to pleura to pleural block versus Paravertebral block for post thoracic surgery analgesia.

Primary outcome:

Postoperative morphine consumption in the first 24 hours after surgery.

Secondary outcomes:

* Time to the first rescue analgesia .
* The amount of rescue analgesics.

· Postoperative visual analog scale pain scores.
* Complications as inadvertent pleural puncture, intravascular injection, epidural, subdural and subarachnoid injection, hypotension, bradycardia\& local Anesthetic systemic toxicity .

Conditions

  • Thoracotomy Surgery
  • Analgesia
  • Thoracic Paravertebral Block

Interventions

DRUG

Group A (Thoracic Paravertebral Block )

Patients received 20 mL of 0.25% levobupivacaine after the paravertebral space after passing through the superior costotransverse ligament

DRUG

Group B : thoracic Mid-Point Transverse Process to Pleural Block

Patients received 20 mL of 0.25% levobupivacaine between the mid-point of the posterior border of the transverse process and the pleura.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07799844 on ClinicalTrials.gov